Associate Professor, Dermatology, University of Pittsburgh School of Medicine
Dermatology
Dr. Laura K. Ferris, MD
|
|
Give Review
Laura K. Ferris, MD works in the field of Dermatology. He studied medicine at University of Maryland School of Medicine. University of Maryland School of Medicine has a rank of 37 in research and a 52 in primary care He received awards:"CMS Meaningful Use Stage 1 Certification", "Eugene Sydney Bereston Award of Excellence in Dermatology", "Donaldson Prize for Excellence in Pathology", "Janet M. Glasgow Memorial Achievement Citation", "Alpha Omega Alpha" and "Phi Beta Kappa". Dr. Laura K. Ferris is a published physician. He has 33 publications published. The most current publication "Computer-aided classification of melanocytic lesions using dermoscopic images." He accepts Medicare.
Publications
- Computer-aided classification of melanocytic Lesions using dermoscopic images.
- Promoting Safe Use of Isotretinoin by Increasing Contraceptive Knowledge.
- Efficacy, Safety, and Out-of-pocket Costs are the Most Important Factors to Patients in Choosing a Psoriasis Therapy.
- Individual and ecological factors associated with early detection of nodular Melanoma in the United States.
- Melanoma depth in patients with an established dermatologist.
- Anti-IL-36R antibodies, potentially useful for the treatment of Psoriasis: a patent evaluation of WO2013074569.
- Women's Experiences With Isotretinoin Risk Reduction Counseling.
- Compliance with pregnancy prevention measures during isotretinoin therapy.
- Three cases of scalp melanomas discovered by Hairdressers.
- Diagnostic inaccuracy of smartphone applications for Melanoma detection-reply.
- Characteristics and survival of patients with invasive amelanotic Melanoma in the USA.
- Epidemiology of Ophthalmologic Disease Associated with Erythema Multiforme, Stevens-Johnson Syndrome, and Toxic Epidermal Necrolysis in Hospitalized Children in the Un...
- Diagnostic inaccuracy of smartphone applications for Melanoma detection.
- The diagnostic evaluation of MelaFind multi-spectral objective computer vision system.
- Signaling through Purinergic Receptors for ATP Induces Human Cutaneous Innate and Adaptive Th17 Responses: Implications in the Pathogenesis of Psoriasis.
- Anti-cytokine therapy in the treatment of Psoriasis.
- Screening for Melanoma in aging patients.
- Human Beta-Defensin 3 Induces Maturation of Human Langerhans Cell-Like Dendritic Cells: An Antimicrobial Peptide that Functions as an Endogenous Adjuvant.
- New diagnostic AIDS for Melanoma.
- The efficacy and safety of infliximab in patients with plaque Psoriasis who had an inadequate response to etanercept: Results of a prospective, multicenter, open-label...
- Cutaneous apocrine carcinoma masquerading as head and neck Cellulitis: an ominous sign.
- Surveillance of patients for early detection of Melanoma: patterns in dermatologist vs patient discovery.
- The influence of age and sex on reasons for seeking and expected benefits of Skin cancer screening.
- Development of subacute cutaneous lupus erythematosus associated with the use of imiquimod to treat Actinic keratoses.
- Treatment of postsurgical pyoderma gangrenosum with a high-potency topical steroid.
- An extensive case of dermonecrotic arachnidism.
- Drug-induced bullous pemphigoid caused by a generic Canadian medication obtained over the internet.
- Re: Botulinum toxin for the treatment of facial flushing.
- Human β-defensin 3 promotes NF-κB-mediated CCR7 expression and anti-apoptotic signals in squamous Cell carcinoma of the head and neck.
- Advances and short comings in the early diagnosis of Melanoma.
- The performance of MelaFind: a prospective multicenter study.
- Mutations in the human SC4MOL gene encoding a methyl sterol oxidase cause psoriasiform Dermatitis, microcephaly, and developmental delay.
Schools
University of Maryland At Baltimore Professional Schools
Procedures Preformed
- Acne Surgery
- Destruction of Benign Skin Lesion
- Destruction of Malignant Skin Lesion
- Destruction of Penile Lesion
- View All
Conditions Treated
- Acne
- Actinic Keratosis
- Basal Cell Carcinoma
- Benign Skin Lesion
- View All
Doctors Specialties
- Dermatology
Accepted Insurances
Awards
- CMS Meaningful Use Stage 1 Certification
- Eugene Sydney Bereston Award of Excellence in Dermatology
- Donaldson Prize for Excellence in Pathology
- Janet M. Glasgow Memorial Achievement Citation
- Alpha Omega Alpha
- Phi Beta Kappa
Education
-
University of Pittsburgh Medical Center -
University of Maryland School of Medicine -
Johns Hopkins University
Hospital
-
UPMC Presbyterian Shadyside
Drug Facts
| NPI NUMBER | 1043283229 | |
| NPPES Provider LastName | FERRIS | |
| NPPES Provider FirstName | LAURA | |
| NPPES Provider ZIPCode | 152133403 | |
| NPPES Provider State | PA | |
| Specialty Description | Dermatology | |
| Total Claim Count | 1380.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1043283229 |
| Last Name Of The Provider | FERRIS |
| First Name Of The Provider | LAURA |
| View All |
Similar Doctors
|
|
Dr. Joseph B. Bikowski Jr., MD
 This Doctor is OpenDoctor Recommended.
|
|
Dr. Suzan K. Obagi, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Sharon L. Hrabovsky, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Alaina J. James, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Nancy S. House, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Katie L. O'Brien, PA-C |